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During development and regeneration, proliferation
of tissue-specific stem cells is tightly controlled to
produce organs of a predetermined size. The molec-
ular determinants of this process remain poorly
understood. Here, we investigate the function of
Yap1, the transcriptional effector of the Hippo
signaling pathway, in skin biology. Using gain- and
loss-of-function studies, we show that Yap1 is a crit-
ical modulator of epidermal stem cell proliferation
and tissue expansion. Yap1 mediates this effect
through interaction with TEAD transcription factors.
Additionally, our studies reveal that a-catenin, a
molecule previously implicated in tumor suppression
and cell density sensing in the skin, is an upstream
negative regulator of Yap1. a-catenin controls Yap1
activity and phosphorylation by modulating its inter-
action with 14-3-3 and the PP2A phosphatase.
Together, these data identify Yap1 as a determinant
of the proliferative capacity of epidermal stem cells
and as an important effector of a ‘‘crowd control’’
molecular circuitry in mammalian skin.
INTRODUCTION
During mammalian development, proliferation and cell death of
tissue-specific progenitor and stem cells (SCs) need to be tightly
monitored and controlled to produce organs of a predetermined
size. Experimental manipulation of SC numbers or activity during
embryogenesis can thus have striking effects on the final size of
certain organs (Depaepe et al., 2005; Kim et al., 2005; Stanger
et al., 2007). Such exquisite regulatory mechanisms also orches-
trate homeostasis of adult tissues and regenerative processes
whereby the final shape and size of organs can be restored after
cellular loss. Though a number of signaling molecules have been
implicated in controlling SC proliferation, little is known about782 Cell 144, 782–795, March 4, 2011 ª2011 Elsevier Inc.endogenous mechanisms that ‘‘sense’’ or provide information
about organ size. It is also unclear how these mechanisms relay
needs for tissue growth to its resident SCs and how these cues
are translated into SC proliferation or apoptosis.
The Hippo signaling pathway was initially discovered in
Drosophila as a potent mechanism that restricts tissue size by
limiting cell proliferation and promoting apoptosis. At the core
of this pathway is a kinase cascade composed of four tumor
suppressors, including Hippo (Hpo) andWarts (Wts) and its regu-
latory proteins Salvador and Mats (Harvey et al., 2003; Lai et al.,
2005; Pantalacci et al., 2003;Wu et al., 2003; Xu et al., 1995). The
Hpo-Sav complex phosphorylates and activates the Wts-Mats
complex, which in turn phosphorylates and inactivates the
transcriptional coactivator Yorkie (Yki) (Huang et al., 2005; Oh
and Irvine, 2008). Yki phosphorylation prevents its nuclear trans-
location (Dong et al., 2007; Oh and Irvine, 2008; Zhao et al.,
2007), wherein it acts as a coactivator for the TEAD/TEF family
transcription factor Scalloped (Sd) (Wu et al., 2008; Zhang
et al., 2008). This core set of Hippo signaling components is
highly conserved in mammals, and orthologs of Hpo (Mst1/2),
Sav (WW45), Wts (Lats1/2), and Yki (Yap1) exhibit similar
biochemical properties in cultured cells (Dong et al., 2007; Oka
et al., 2008; Zhao et al., 2007). The importance of Hippo signaling
in mammalian organ size control has been studied extensively in
the liver, where loss of Mst1/2 or Sav or overexpression of Yap1
lead to hepatomegaly (Camargo et al., 2007; Dong et al., 2007;
Lu et al., 2010; Song et al., 2010; Zhou et al., 2009). However,
to what extent these predicted epistatic and functional relation-
ships are conserved and active in other tissues remains uncer-
tain (Zhou et al., 2009).
Compared with the core kinase cascade regulating Yki phos-
phorylation, components acting upstream of this complex are
less well defined. Earlier work in Drosophila has implicated the
apical membrane-associated FERM-domain proteins Merlin
(Mer), Expanded (Ex), and Kibra as pathway components
upstream of Hpo (Baumgartner et al., 2010; Genevet et al.,
2010; Hamaratoglu et al., 2006). Recent studies further impli-
cated the apical transmembrane protein Crumbs (Crb) (Robin-
son et al., 2010) and the atypical cadherin Fat (Ft) (Hariharan,
2006) as modulators of the fly Hippo pathway. However, with the
exception of the mammalian Merlin ortholog NF2 (Zhang et al.,
2010), the significance and relevance of these proteins in regu-
lating the activity of Yap1 in vivo in mammals are largely unclear.
The identification of physiological upstream regulators of
mammalian Hippo signaling could provide important insights
into the mechanisms sensing and controlling organ size.
The mammalian epidermis is a rapidly regenerating epithelial
tissue whose maintenance depends on the self-renewing ability
of epidermal SCs residing in the basal layer. After division, short-
lived progenitor cells leave the basal layer and move through the
suprabasal layers to the tissue surface as they terminally differ-
entiate (Fuchs, 2007). Epidermal growth must be carefully
balanced: inadequate proliferation results in thinning of the
skin and loss of protection, and excessive growth is character-
istic of hyperproliferative disorders. During development, the
epidermis must be able to sense needs for expansion and
replace basal vacancies, and during regeneration, cells must
migrate and proliferate but also sense when to stop after wound
closure. It has been postulated that adherens junctions (AJs),
cadherin and catenin-based cell adhesion structures, might
have a function in sensing epidermal cell density and restricting
basal cell proliferation (Lien et al., 2006b). For instance, loss of
some, but not all, AJ components, such as a-catenin or p120-
catenin, triggers severe epidermal hyperproliferation and tumors
in transgenic mice (Kobielak and Fuchs, 2006; Perez-Moreno
et al., 2006; Vasioukhin et al., 2001). The mechanisms acting
downstream of these complexes are not fully understood.
Intriguingly, it has been recently found that NF2 can modulate
epidermal development via an association with AJs, specifically
a-catenin, and the Par3 polarity complex (Gladden et al., 2010).
These findings raise the possibility that signaling cues that
regulate cell density and cell polarity could converge on the regu-
lation of downstream Hippo signaling components.
Here, we utilize gain- and loss-of-function models in mice to
show that Yap1 is an essential regulator of epidermal mainte-
nance and SC proliferative capacity. In addition, we identify
a-catenin, an AJ component and a known tumor suppressor in
the skin, as a crucial upstream negative regulator of Yap1 in
epidermal cells in vitro and in vivo. Our work identifies a direct
link between a signaling component of cell density-dependent
AJs and a transcriptional regulator and provides a paradigm
for the regulation of tissue expansion in response to extracellular
cues.
RESULTS
Activation of Yap1 Can Expand the Epidermal SC
Compartment
In newborn mouse epidermis, Yap1 has a dynamic subcellular
localization pattern in the basal compartment where it is present
in the nucleus in some cells and in the cytoplasm/membrane of
others. Expression of Yap1 is reduced and in a more diffuse
nonnuclear pattern in the suprabasal-differentiated cell layers
(Figure 1A). This pattern is also observed in cultured human
keratinocytes in which high cellular densities lead to Yap1 reloc-
alization out of the nucleus (Figure 1B). Thus, regulation of Yap1
subcellular localization might be important for the switchbetween proliferative and terminally differentiating compart-
ments. To test this, we utilized transgenic mice carrying a doxy-
cycline (Dox)-inducible allele of a mutated version of Yap1
(S127A). This mutation results in the enhanced nuclear localiza-
tion of Yap1 (Camargo et al., 2007; Dong et al., 2007; Zhao et al.,
2007). To restrict Yap1 activation to the epidermis, we developed
a binary genetic strategy based on the Cre-mediated activation
of a reverse tetracycline-dependent transactivator selectively
in the progeny of K14-expressing progenitors of stratified
epithelia (Belteki et al., 2005; Dassule et al., 2000) (Figure S1A
available online). Mice carrying these transgenes will be referred
to as Tg hereafter. Eight days after Dox administration, adult Tg
mice developed thickening and wrinkling of the skin. Histological
analyses demonstrated that, contrary to the typical one-/two-
cell layer common to adult mouse epidermis, Tg skin developed
into a multilayered epithelium (Figure 1C). Staining for the prolif-
eration marker Ki-67 revealed a substantial increase in the
number of proliferating basal cells and an extension of the prolif-
erative domain into the suprabasal layers, normally quiescent in
control skin (Figure 1D). Tg epidermis contained an abundance
of cells expressing progenitor markers such as K5 and K14,
whereas expression of the differentiation markers K10 and
loricrin was mostly abrogated (Figure 1E and Figure S1B). Addi-
tionally, the number of cells expressing p63, a SC marker and
essential regulator of stemness in stratified epithelia (Senoo
et al., 2007), was amplified in Tg skin (Figure 1F). Tg skin failed
to express hair follicle SC markers such as K15, or Sox9 (data
not shown). These results suggested that activation of Yap1
induced expansion of an undifferentiated stem/progenitor cell
population in the interfollicular epidermis. We then compared
the clonogenic capacity of primary keratinocytes isolated
7 days after Dox administration. Skin of Tg mice had a >5-fold
increase in the number of colony-forming cells compared to
controls after Yap1 activation in vivo (Figure 1E). Moreover, serial
plating assays, typically used to distinguish self-renewing SCs
versus shorter-lived progenitors, revealed that Yap1 activation
enhanced the SC proliferative capacity by 10-fold in secondary
and tertiary platings (Figure 1G and Figure S1C). Taken together,
these experiments demonstrate that activation of Yap1
promotes the proliferation of epidermal stem and progenitor
cells and that its regulation is critical in maintaining normal skin
homeostasis.
Activation of Yap1 Can Lead to Squamous Cell
Carcinoma-like Tumors
Tg mice became ill 8 days after Dox induction, likely because of
similar dysplastic changes inmucosal tissues such as the tongue
(Figure S1D). In order to assess the long-term effects of Yap1
activation, newborn Tg and control skin was grafted onto
Nude-mouse recipients followed by Dox administration.
Epidermal thickening, hyperkeratosis, and stunted hair growth
were evident in Tg-grafted mice shortly after grafting. Beginning
at 20 days, Tg grafts developed large tumor-like masses that
subsequently ulcerated (Figure 2A). Histological analyses re-
vealed hyperplasia and multiple epidermal invaginations into
the dermis as early as 9 days after grafting (Figure 2B). These
lesions were epidermal in nature, as judged by staining with a
pan-cytokeratin antibody and by their expression of keratin 6,Cell 144, 782–795, March 4, 2011 ª2011 Elsevier Inc. 783
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Figure 1. Activation of Yap1 Leads to Epidermal Stem Cell Expansion
(A) Yap1 expression (brown) indicated by immunohistochemical staining on E18.5 murine wild-type epidermis.
(B) Immunofluorescence staining for Yap1 shows a dynamic localization pattern in human keratinocytes that is cell density dependent.
(C) Hematoxylin and eosin (H&E) staining shows an abnormally thick epidermis and hyperkeratinization in adult Tg mouse skin after 8 days of doxycycline (Dox)
induction.
(D–E) Immunofluorescence analysis on frozen sections of adult epidermis shows an expansion of the proliferative Ki-67-positive compartment as well as the stem
cell compartment (p63-positive, K5-positive) in Tg skin after 8 days of dox induction. Dashed line marks epidermal-dermal junction.
(F) Rhodamine B staining of primary mouse keratinocytes, isolated from 8 day Dox-treated Tg mice and cultured for 9 days on feeders, shows a significant
expansion of the epidermal stem cell compartment demonstrated by a higher colony-forming efficiency in Tg skin.
(G) Rhodamine B staining and colony counts show a significant increase in the self-renewal capacity of colony-forming progenitors after Dox administration
measured by serial replating assays (shown is passage 2, P2).
Data are presented as mean ±. *p < 0.05; **p value < 0.01. Scale bars, 20 mm. See also Figures S1A–S1C.which is expressed anomalously in hyperproliferative states (Fig-
ure 2C). Donor origin of the tumors was confirmed by their
expression of the Yap1 transgene (Figure 2D and Figure S1E).
Overall, the morphological perturbations resembled those of
squamous cell carcinoma (SCC) in situ in human (Figure 2B).
By 42 days, full dermal invasion was evident, and this was asso-
ciated with the rupture of the basement membrane (Figure 2E).
At this stage, tumors resembled human sarcomatoid SCC, char-
acterized by the presence of invasive atypical proliferating
spindle cells intermingled with keratinized centers (Figure 2B
and Figures S1F and S1G). As predicted from their morphology,
invading cells stainedmostly negative for keratinmarkers but ex-
pressed themesenchymalmarker vimentin, indicating a potential
epithelial-mesenchymal transition, a common occurrence in
advanced human SCC (Figure 2E). Tumors were also assessed
for their renewal by performing secondary transfers by subcuta-
neous injection into Nude mice. All transplantations gave rise to
large masses of similar morphology as their primary counter-784 Cell 144, 782–795, March 4, 2011 ª2011 Elsevier Inc.parts (Figure S1H). Our results here demonstrate that proper
regulation of Yap1 activity is essential for tumor suppression in
the epidermis.
Loss of Yap1 Results in Failure of Skin Expansion
To test the role of endogenous Yap1 in epidermal biology, we
generated a conditional floxed (fl) allele of Yap1 by gene target-
ing (Figure S2A). Deletion of loxP-flanked exons 1 and 2 of Yap1
after breeding to K14-Cre mice resulted in epidermis lacking
Yap1 protein (Figures S2B–S2D). K14-Cre Yap1(fl/fl) mice will
be referred to as cKO mice hereafter. cKO mice were either
aborted or died shortly after birth. Gross examination of mutant
embryos at E18.5 revealed thinner and fragile skin and absence
of epidermal tissue covering the distal part of the limbs (Fig-
ure 3A). Assessment of skin permeability using the toluidine
blue dye revealed a complete loss of epidermal barrier function
in the regions described and around the mouth and nose (Fig-
ure 3B). Histological analyses of the proximal limb skin of cKO
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Figure 2. Activation of Yap1 Leads to Tumor Formation
(A) Gross morphology of Ctr and Tg grafts 14 and 42 days after beginning of Dox treatment. Note hyperkeratosis and stunted hair growth in Tg 14d graft and
ulceration of skin and subcutaneous tumor mass in Tg 42d graft.
(B) H&E staining of Ctr and Tg grafts 9 and 42 days after Dox induction show an invasion of underlying dermis by invasive keratinocytes derived from the Tg graft.
Arrow points out to neighboring normal Nude mouse epidermis. White dashed line indicates border of carcinoma to normal Nude dermis.
(C) Expression of cytokeratin (CK) and keratin 6 (K6) in Tg grafts treated 9 days with Dox as shown by immunohistochemistry.
(D) Immunohistochemistry for Yap1 on Tg grafts with 9 and 42 days Dox treatment reveals epithelial origin of the tumor. Arrow points at Nude mouse epidermis.
(E) Immunohistochemistry for vimentin (Vim) and integrin-b4 (b4-int) on Tg grafts with 42 days of Dox induction.
Scale bars, 100 mm. See also Figure S1D–S1H.mice revealed a thinner epidermis, reduced stratum corneum,
and disorganized epidermal architecture (Figure 3C). Notably,
the basal layer was hypoplastic, and basal cells had lost their
columnar organization and adopted a flat morphology, typical
of suprabasal differentiated cells (Figure 3C). These phenotypes
were also observed in the back skin of cKO mice but were less
severe.
At E18.5, mutant cells expressing K10, an early differentiation
marker, were nearly juxtaposed to the basement membrane in
contrast to control skin where the basal layer was more
pronounced (Figure 3D). Staining of cKO skin with progenitor
markers demonstrated their abnormal morphology and reduc-
tion in numbers (Figure 3E). Staining with the proliferation marker
phosphohistone H3 (pH3) revealed a >3.5-fold decrease in the
number of proliferating basal cells in proximal limb skin of cKO
mice (Figure 3F and Figure S2E). No discernible difference in
apoptotic cells was detected, as judged by staining with active
caspase 3 (data not shown). To directly address whether Yap1
deletion had an effect on the proliferative potential of epidermal
SCs, we performed clonogenic assays. These experiments
demonstrated a >50-fold decrease in the number of colony-forming cells and a decrease in colony size in cKO epidermis
(Figure 3G and Figure S2F). This reduction in proliferative poten-
tial is likely the cause of the absence of skin in distal limb areas,
where due to growth demands during development, the prolifer-
ation rate at E18.5 is more than 3-fold that of back skin (Fig-
ure S2E). These results indicate that Yap1 is required for the
maintenance of epidermal proliferative potential during develop-
ment and, together with our gain-of-function experiments,
suggest that levels of active Yap1 are a critical and physiological
determinant of epidermal SC proliferative capacity.
TEAD Interaction Is Critical for the Role of Yap1
in the Epidermis
We next explored whether the ‘‘canonical’’ Hippo pathway
components played a role in regulating Yap1 in the epidermis.
In mammals, the transcription factors TEAD1–4 have been
shown to interact with Yap1 and to mediate some of its prolifer-
ative effects in vitro (Vassilev et al., 2001; Zhao et al., 2008). To
test whether TEAD factors were also involved in the regulation
of epidermal biology, we generated a reporter construct carrying
multimerized copies of the consensus TEAD DNA bindingCell 144, 782–795, March 4, 2011 ª2011 Elsevier Inc. 785
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Figure 3. Yap1 Is Required for the Maintenance of the Proliferative Capacity of Epidermal Stem Cells
(A) Gross morphology of representative control (Ctr) and cKO E18.5 embryos. Note absence of skin in distal limbs, eyes, and ears and overall thinner skin.
(B) Toluidine blue skin barrier assay in E18.5 mice reveals absence of epidermal barrier in limbs, ears, nose, and mouth.
(C) H&E staining shows a decrease in epidermal thickness in cKO skin compared to the Ctr (indicated by bracket). Note the flat morphology of basal cells and
disorganized epidermal architecture. Dashed line represents epidermal-dermal junction.
(D and E) Immunofluorescence on frozen E18.5 epidermis reveals signs of basal cell depletion in cKO skin. Note the reduction of keratin 10 (K10)-negative, keratin
5 (K5)-positive progenitor/stem cells juxtaposed to the basement membrane (b4). Note the background staining for K5 in stratum corneum of cKO.
(F) Marked reduction in number of proliferative basal cells in cKO limb skin as measured with an antibody against phosphohistone H3 (pH3). Results represent
measurements of at least five different fields in three different animals.
(G) Reduction in the number of colony-forming progenitors in E18.5 skin. Rhodamine B stain and colony counts were performed at day 8 after plating and are
representative of two independent experiments.
Data are presented as mean ± standard deviation (error bars). **p < 0.01; ***p < 0.005. Scale bars, 20 mm. See also Figure S2A–S2F.sequence (TBS) to monitor their endogenous activity (Figure 4A).
TBS reporter expression in a HaCaT keratinocyte cell line was
highly responsive to Yap1, as its overexpression augmented
reporter signal and its knockdown (KD) reduced reporter activity
(Figure 4A). Proliferating cells in the periphery of colonies ex-
pressed the highest levels of the reporter, and reporter signal
decreased when these cells were cultured at high densities,
thus mimicking the observed pattern of Yap1 activity (Figure 4B).
Given the functional overlap among the four mammalian TEAD
proteins, we decided to test their role in epidermal biology in vivo
by genetically disrupting their interaction with Yap1. Through
homologous recombination in ES cells, we mutated the Serine
at position 79 of Yap1 to Alanine (S79A) (Figures S3A and
S3B). The ortholog serine in human Yap1 (S94) is necessary to786 Cell 144, 782–795, March 4, 2011 ª2011 Elsevier Inc.mediate a physical interaction with the TEAD proteins, but not
with other DNA-binding cofactors (Zhao et al., 2008). The
predicted consequences of this mutation were tested in
Yap1fl/S79A mouse embryonic fibroblasts after administration of
Cre, and we found that, whereas the overall levels of Yap1
protein were unchanged, its ability to interact with TEAD factors
was mostly ablated (Figure 4C). We next generated K14-Cre
Yap1fl/S79A (S79A) mice, in which only the Yap1 mutant protein
would be expressed in the epidermis of mice starting at E14.5.
These mice died at birth and fully phenocopied cKO mice (Fig-
ure 4D). S79A animals lacked epidermis in the distal part of the
limbs, eyes, and ears. Mutant limb skin was thinner, with
a reduced number of proliferating basal cells lying flat above
the basal membrane (Figure 4D and Figure S3C). Clonogenic
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Figure 4. Yap1 Function in the Skin Is Mediated through TEAD Factors
(A) A HaCaT keratinocyte cell line carrying multimerized TEAD-binding sequences (TBS) upstream of a minimal promoter (minP) and an mCherry reporter is
responsive to expression of Yap1-S127A, whereas RNAi KD of Yap1 downregulates reporter levels. Cells that have been transfected with a scrambled
control-RNAi display reporter activity at basal levels.
(B) TBS reporter dynamics mimic Yap1 activity/localization. (Top) TBS-mCherry shows a dynamic fluorescence pattern with keratinocytes at the edge of
a growing colony expressing higher mCherry levels. (Bottom) Reporter signal decreases significantly at high cellular densities.
(C) Physical interaction between Yap1 and TEAD1 is virtually ablated in Adenovirus-Cre (+Cre)-treated Yapfl/S79A embryonic fibroblasts. Immunoprecipitation (IP)
was performed with an anti-Yap1 antibody followed by immunoblotting for TEAD1. Loading control b-tubulin (b-tub).
(D) Gross morphology of control (Ctr) and K14-Cre Yapfl/S79A E18.5 embryos. Note the absence of skin in distal limbs and thinner skin with flat basal cells.
(E) Reduction in the number of colony-forming progenitors and proliferative potential in the skin of E18.5 K14-Cre Yapfl/S79A mice, as demonstrated by colony
assays stained with Rhodamine B.
Data are presented as mean ± standard deviation (error bars). **p < 0.01; ***p < 0.005. Scale bars, 20 mm. See also Figures S3A–S3C.assays demonstrated a depletion of SC activity similar to cKO
mice (Figure 4E). These results provide genetic evidence that
TEADs are likely to be the major transcriptional partners of
Yap1 in epidermal proliferation.
a-Catenin Interacts with Yap1 and 14-3-3
The mammalian orthologs of the Drosophila hippo kinase, Mst1
and Mst2, function upstream of Yap1 to mediate its phosphory-
lation and inactivation (Zhao et al., 2007). Deletion of both Mst1
and Mst2 in the liver results in Yap1 activation and hepato-
megaly, suggesting that these kinases can act as bona fidenegative regulators in vivo (Song et al., 2010; Zhou et al.,
2009). We assessed whether deletion of Mst1/Mst2 in the skin
would lead to similar phenotypes as Yap1 activation. Surpris-
ingly, the epidermis of mice carrying a skin-specific deletion of
Mst1/Mst2 displayed no abnormalities and no evidence of
hyperplasia in mice up to 5 months of age (Figures S4A and
S4B). This was accompanied by no changes in Yap1 S127
phosphorylation in Mst1/Mst2 null keratinocytes (Figure S4C).
Additionally, KD of Mst1/Mst2 in the HaCaT-TBS reporter line
produced no change in reporter activity or Yap1 nuclear localiza-
tion (Figures S4D and S4E). Similarly, knockdowns of Lats1 andCell 144, 782–795, March 4, 2011 ª2011 Elsevier Inc. 787
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Figure 5. a-Catenin Interacts with Yap1 and 14-3-3
(A) Confluent HaCaT cell lysates (input) were used for an IP with an antibody against Yap1 or Pu.1 (Ctrl) and IP and post-IP material blotted with an antibody for
a-catenin.
(B) 293T cells were cotransfected with the indicated plasmids followed by IP with either GST or FLAG-beads. Co-IPs demonstrate an association between
full-length Yap1 and a-catenin and a largely diminished association between a-catenin and the YapS127A mutant. IB, immunoblotting; WCL, whole-cell lysate.
(C) Calcium-induced differentiation in primary human keratinocytes leads to translocation of Yap1 into membrane regions that colocalize with a-catenin.
(D) Characterization of Yap1 domains that are important for the interaction with a-catenin.
(E and F) In vitro pull-down (PD) of recombinant Yap1 and a-catenin in the presence or absence of 14-3-3.
(G) In vitro pull-down of recombinant a-catenin and 14-3-3 in the presence of phosphorylated recombinant Yap1.
(H) Immunoprecipitation of Yap1 and a-catenin demonstrates that the biochemical interaction is dependent on 14-3-3.
Scale bars depicted are 10 mm. See also Figures S4A–S4E, Figures S5A and S5B, and Table S1.Lats2, the orthologs of Drosophila warts, did not lead to
increased reporter activity or enhanced Yap1 nuclear localiza-
tion (Figures S4D and S4E). These results suggested that Yap1
might be regulated by alternative mechanisms in keratinocytes
that are independent of the predicted canonical Hippo pathway
kinases. In order to identify potential alternative upstream regu-
lators of Yap1 activity, we performed coimmunoprecipitation
(co-IP) experiments followed by mass spectrometry (MS) anal-
ysis in high-density HaCaT cultures. Unexpectedly, this screen788 Cell 144, 782–795, March 4, 2011 ª2011 Elsevier Inc.revealed that the most common interaction partner of Yap1 in
keratinocytes corresponded to a-catenin, an important tumor
suppressor in stratified epithelia (Table S1).
We next validated our mass spectrometry data by character-
izing the interaction of Yap1 with a-catenin. Endogenous co-IP
experiments in confluent HaCaT cells and keratinocytes directly
isolated from skin, and pull-downs following transfection of
tagged forms of Yap1 and a-catenin in 293T cells further demon-
strate the biochemical interaction (Figures 5A and 5B and
Figure S5A). Confocal microscopy studies in primary human
keratinocytes corroborate these findings and reveal that Yap1
can begin to colocalize with a-catenin shortly after induction of
differentiation following calcium treatment (Figure 5C). With
more time in calcium or at high cell densities, nuclear Yap1 is
depleted, with some of it colocalizing with a-catenin at the
membrane and some accumulating in a cytoplasmic pool
(Figure S5B).
Phosphorylation of Yap1 at Ser127 creates a 14-3-3 binding
site that has been shown to be crucial for the regulation of its
activity (Zhao et al., 2007). Remarkably, disruption of 14-3-3-
mediated regulation by mutation of Yap1 Ser127 to alanine
nearly abolished the interaction between Yap1 and a-catenin
(Figures 5B and 5D). The participation of 14-3-3 in Yap1 binding
to a-catenin is further evidenced by the presence of a large
number of 14-3-3 peptides found in our Yap1 mass spectro-
metry pull-downs (Table S1). We also find that the WW domains
of Yap1, previously shown to be important for negative regula-
tion by inhibitory kinases (Oka et al., 2008), are also required
for its efficient interaction with a-catenin (Figure 5D).
We next examined whether the interaction between a-catenin
and Yap1 was direct using in vitro binding assays. Bacterially
purified a-catenin and recombinant Yap1 purified from Sf9 cells
were coincubated and subjected to pull-down assays. Our
results reveal a lack of direct interaction between these two
proteins (Figures 5E and 5F). Given that phosphorylation at
Yap1 S127 and subsequent 14-3-3 binding are critical for the
Yap1 and a-catenin association in cells, we tested whether
14-3-3 could allow for the formation of a tripartite complex
in vitro. Indeed, the addition of bacterially purified 14-3-3
resulted in the association of Yap1 and a-catenin (Figures 5E
and 5F). As predicted, this association was dependent on
Yap1 phosphorylation, as pretreatment of phosphorylated re-
combinant Yap1 with lambda phosphatase resulted in loss of
complex formation (Figures 5E and 5F). Our results also provide
evidence for a direct physical interaction between a-catenin and
14-3-3, which can be enhanced by the presence of phosho-
Yap1 (Figure 5G). Additionally, expression of a dominant-nega-
tive 14-3-3mutant (K49E) inmammalian cells leads to a reduction
of Yap1 and a-catenin binding (Figure 5H). Thus, these data
uncover a-catenin as a binding partner for Yap1 and demon-
strate that 14-3-3 is critical for this biochemical interaction.
a-Catenin Regulates Yap1 Localization and Activity
To test whether AJs are functionally important for the nonnuclear
localization and inactivation of Yap1 at high cellular densities,
keratinocyte cultures were treated with the calcium chelator
EGTA. After only 1 min of EGTA treatment, the subcellular local-
ization of Yap1 turned predominantly nuclear (Figure 6A and Fig-
ure S5C). The rapid kinetics of these observations indicates that
AJs play a functional role in inactivating Yap1 and that the same
pool of Yap1 can rapidly relocalize to the nucleus. To more
specifically dissect the role of individual AJ proteins in regulating
Yap1 activity, we depleted their expression in HaCaT and 293T
cell lines carrying the TBS reporter. Remarkably, a robust activa-
tion of the reporter was observed after a-catenin KD, similar to
levels obtained after depletion of the known upstream regulator
NF2. A weaker but significant response was obtained afterdepletion of p120-catenin, and no reporter activation was
observed after KD of b-catenin, E-cadherin, P-cadherin, or
both E- and P-cadherins (Figure 6B and Figures S5D and S5E).
a-catenin depletion activated the TBS reporter in several other
cell lines tested, indicating a conserved phenomenon across
epithelial cell types (Figure S5F). Silencing of a-catenin in
confluent keratinocytes resulted in Yap1 relocalization to the
nucleus and the formation of a Yap1/TEAD nuclear complex (Fig-
ure 6C-D). a-catenin depletion was also accompanied by
a reduction in the inhibitory phosphorylation at Yap1-S127 and
minimal changes in the activation status of the Mst and Lats
kinases (Figure 6E), suggesting that the regulatory effects of
a-catenin might be independent of these kinases.
To extend these observations and to test whether a-catenin
could be an important negative regulator of Yap1 in vivo, we
examined Yap1 localization in a-catenin mutant tissues. We first
analyzed Yap1 localization in epidermis of E18.5 mice with
a K14-Cre driven deletion of a-catenin. Skin of control mice dis-
played the typical heterogeneous subcellular localization pattern
in which only a few basal cells display predominant nuclear Yap1
protein (Figure 6F). This patternwas drastically changed in a-cat-
enin mutant epidermis where basal cells were, in their great
majority, positive for nuclear Yap1 and showed substantially
enhanced nuclear staining (Figure 6F and Figure S5G). Addition-
ally, in some regions, we observed nuclear Yap1 staining extend-
ing into the suprabasal cell compartment. Nuclear Yap1 was
never seen suprabasally in control tissue (Figure 6F). We next
evaluated the localization of Yap1 in a panel of 19 human skin
SCCs that expressed varying levels of a-catenin (Figure S5H).
As shown in Figure S5H, no or low expression of a-catenin
clearly correlated with enhanced nuclear Yap1 localization in
these tumors.
Having established that a-catenin is crucial for the inactivation
of Yap1 in keratinocytes in vitro and in vivo, we tested whether
ectopic expression of a-catenin could result in the recruitment
of Yap1 to AJs. Remarkably, enforced expression of a-catenin
in low-density cultures led to the relocalization of Yap1 to
membrane regions containing AJ components (Figure 6G and
Figure S6A). To test whether a different AJ protein could mediate
this recruitment of Yap1 to the membrane, we performed similar
experiments with E-cadherin. Cells that overexpressed E-cad-
herin, however, did not show localization of Yap1 to membrane
regions (Figure S6B). These observations support the idea that
a-catenin plays a direct role in the recruitment of Yap1 to AJs.
This result, together with the siRNA depletion data (Figure 6B),
speaks to the unique ability of a-catenin, and not E/P-cadherin
or b-catenin, to regulate Yap1 localization and activity. These
findings also argue that Yap1 hyperactivation is not due simply
to loss of AJ-mediated cellular adhesion.
Genetic ablation of a-catenin in murine epidermis leads to
keratinocyte hyperproliferation and squamous cell carcinoma
(Kobielak and Fuchs, 2006; Vasioukhin et al., 2001), observa-
tions that are highly reminiscent of the Yap1 gain-of-function
phenotypes described here. Altogether, our data suggest that
the growth-suppressive effects of a-catenin in the epidermis
might be mediated through inactivation of Yap1. We tested
this prediction experimentally and found that reduction of
Yap1 levels in a a-catenin KD HaCaT cell line rescued itsCell 144, 782–795, March 4, 2011 ª2011 Elsevier Inc. 789
Figure 6. a-Catenin Regulates Yap1 Localization and Activity
(A) Disruption of AJs in high-confluent keratinocytes with EGTA results in Yap1 nuclear localization after 1 min of treatment.
(B) Knockdown (KD) of AJ proteins in either HaCaT or 293T cells carrying the TBS-reporter. KD of NF2 is shown as a positive control.
(C and D) KD of a-cat in confluent keratinocytes leads to Yap1 nuclear localization, and interaction with its nuclear partner Tead1 (D).
(E) siRNA-mediated depletion of a-cat in high-density HaCaT cultures leads to loss of Yap phosphorylation at serine 127 (pYap) and unchanged levels of activated
Mst1/2 (pMst) or Lats1/2 (pLats).
(F) Immunohistochemistry for Yap1 in Ctrl and K14-Cre conditional a-catenin mutant (cKO) E18.5 epidermis. Note the enhanced nuclear staining in basal and
suprabasal cells of cKO mice.
(G) Immunofluorescence detection of Yap1 (purple) localization in low-density keratinocytes ectopically expressing GST-a-cat (green). Keratinocytes over-
expressing a-cat show Yap1 localization to sites of cell-cell contact, whereas untransfected cells show nuclear staining and an absence of Yap1 staining at the
cell membrane.
(H) Stable knockdown of a-catenin (a-cat-KD) promotes hyperproliferation in HaCaT cells. However, doxycycline (dox)-induced KD of Yap1 in a-cat-KD cells
slows down the rate of cell proliferation to control (Ctr) levels.
(I) Ectopic expression of a-cat in a HaCaT cells suppresses cell proliferation (a-catOE). This growth inhibition is rescued by the expression of a Dox-inducible
Yap1S127A mutant (Yap1S127A+Dox).
Data are mean ± standard deviation (error bars). ***p < 0.001. Scale bars, 20 mm (A and C), 10 mm (F), and 5 mm (G). See also Figures S5C–S5H and S6A–S6E.hyperproliferative phenotype to the level of control keratinocytes
(Figure 6H and Figures S6C–S6E). Conversely, ectopic expres-
sion of a-catenin suppressed keratinocyte proliferation (Fig-
ure 6I), but expression of Yap1-S127A was able to rescue these
inhibitory effects (Figure 6I).
a-Catenin Binding Prevents Yap1 Dephosphorylation
and Activation
Knockdown of a-catenin results in decreased Yap1 S127 phos-
phorylation, which is likely the cause of increased Yap1 nuclear
localization and activity. To begin understanding the potential
mechanisms linking a-catenin levels and Yap1 phosphorylation,
we performed a Yap1 co-IP followed by MS in a-catenin KD
cells. These experiments revealed a selective interaction of790 Cell 144, 782–795, March 4, 2011 ª2011 Elsevier Inc.Yap1 with the catalytic subunit of the protein phosphatase 2A
(PP2Ac) in cells with reduced a-catenin levels (data not shown).
Co-IP and immunoblotting experiments confirmed this observa-
tion (Figure 7A). These results suggested that loss of a-catenin
could result in a more efficient association of Yap1 and PP2Ac,
which could potentially dephosphorylate Yap1-S127, triggering
its activation. PP2A is a highly promiscuous enzyme that cata-
lyzes the dephosphorylation of a wide range of substrates.
Purified PP2Ac, in fact, is able to efficiently dephosphorylate
Yap1 S127 in vitro in an okadaic acid-dependent manner (Fig-
ure 7B). Importantly, reduction of PP2Ac levels in a-catenin KD
cells suppresses the increase in TBS reporter activity and
S127A phosphorylation observed after depletion of a-catenin
(Figure 7C and Figure S7). Thus, PP2Ac acts downstream or in
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Figure 7. a-Catenin Binding Prevents Yap1 Dephosphorylation and Activation
(A) PP2Ac associates with Yap1 in a-catenin-depleted HaCaT cells. The association of Yap1 and 14-3-3 is diminished in the absence of a-catenin.
(B) Yap1 is dephosphorylated by PP2Ac in vitro. Different concentrations of purified PP2A were incubated with Sf9-purified recombinant Yap1 for 30 min.
(C) siRNA KD of a-catenin increases TBS reporter activation and the dephosphorylation of Yap1. Simultaneous KD of a-catenin and PP2Ac suppresses TBS
reporter transcriptional activity and increase in Yap1 phosphorylation.
(D) Western blot analysis of phospho-Yap levels following an in vitro dephosphorylation competition assay of Yap1 by PP2Ac in the presence of recombinant
14-3-3 and a-catenin.
(E) Schematic model of density-dependent and a-catenin-mediated Yap1 activation.
Data are presented as mean ± standard deviation (error bars). **p < 0.01; ***p < 0.001. See also Figure S7.parallel of a-catenin, and the increased Yap1 activity in a-catenin
KD cells is dependent on PP2Ac activity.
An antagonistic and competitive interaction has been reported
between PP2A and 14-3-3 for different phosphosubstrates
(Chiangetal., 2003;Martin et al., 2008).Hence,we testedwhether
KD of a-catenin would result not only in increased association of
Yap1with PP2Ac, but also in reduced binding to 14-3-3. In effect,
Yap1 does not seem to be bound to 14-3-3 in a-catenin KD kera-
tinocytes (Figure 7A). To determine whether a Yap1, 14-3-3, and
a-catenin complex could be protective against PP2Ac-mediated
dephosphorylation, an in vitro dephosphorylation assay was per-
formed in the presence and absence of these complex-forming
proteins. Though the presence of 14-3-3 alone was not able to
mitigate phosphatase activity, addition of a-catenin to the
complex resulted in diminished dephosphorylation (Figure 7D).
One of the many PP2A complexes has been previously impli-
cated in the regulation of Hippo signaling by controlling phos-
phorylation of the Hpo kinase in Drosophila (Ribeiro et al.,
2010). Our experiments in mammalian cells extend the role of
PP2Ac as a regulator of mammalian Hippo signaling and suggest
that a-catenin might regulate Yap1 activity by modulating its
ability to be dephosphorylated at S127.
DISCUSSION
The present findings provide a mechanistic paradigm for the
regulation of SC proliferation and tissue expansion in responseto extracellular cues. In this molecular circuitry, cellular ‘‘neigh-
borhood’’ information is provided by density-dependent cell-
cell junctions (Figure 7E). A critical and unique component of
these junctions, a-catenin, acts as a signaling molecule to trans-
late this context-dependent information into SC proliferation and
tissue expansion. a-catenin achieves this through modulating
the activity of Yap1, the transcriptional coactivator of the size-
restricting Hippo signaling pathway.
Yap1 as a Critical Regulator of Epidermal SCs
Relatively little is known about the transcriptional networks
controlling epidermal SC maintenance. Arguably, only p63 and
Tcf3/Tcf4 have been implicated as essential factors for the
long-term proliferative capacity of epidermal SCs in vivo
(Nguyen et al., 2009); Senoo et al., 2007). Our work here
provides loss- and gain-of-function genetic evidence indicating
that Yap1 and the TEAD proteins are critical endogenous regu-
lators of epidermal SC and progenitor proliferation. While this
manuscript was under review, Zhang et al. reported that trans-
genic activation of Yap1 in the skin led to an expansion of basal
epidermal progenitors and inhibition of terminal differentiation
(Zhang et al., 2011). These authors also find that nuclear Yap1
progressively declines with age and that it correlates with the
proliferative potential of epidermal progenitors. Our work
corroborates and extends these observations, and together
they highlight the emerging role of Yap1 and TEAD factors in
skin homeostasis. In the future, it will be important to identifyCell 144, 782–795, March 4, 2011 ª2011 Elsevier Inc. 791
the transcriptional targets of this complex that mediate its
function.
Our results also extend previous observations linking Yap1/
TEAD activity to SC function. In the intestine, Yap1 activation
leads to the expansion of an undifferentiated progenitor popula-
tion (Camargo et al., 2007), whereas its deletion causes no
obvious defects during development or homeostasis, though it
impairs regeneration (Cai et al., 2010). Loss of Yap1 in the liver
leads to defective biliary development but unimpaired re-
generation after partial hepatectomy (Zhang et al., 2010;
F.D.C., unpublished data). Thus, it seems that the requirement
for endogenous Yap1 in tissue-specific SCs varies significantly
according to the cellular context. The intrinsic need for Yap1/
TEAD activity in epidermal SCs during development is more
akin to the role that this complex plays in human embryonic
SCs, in which it is required for their self-renewal and suppression
of differentiation (Lian et al., 2010).
a-Catenin as a Regulator of Yap1 Activity
Our findings provide additional insight into the role of a-catenin in
growthand tumor suppression.Previously,a-cateninwasconsid-
ered to be a simple structural linker between the cadherin/catenin
complex and the actin cytoskeleton. During the past several
years, it has become evident that a-catenin also functions as
a signaling molecule in a variety of cellular processes in addition
to its role in cellular adhesion (Stepniak et al., 2009). Interestingly,
ablation of epidermal E- and P-cadherins leads to AJ disruption,
defects in intracellular adhesion, and epidermal integrity but no
significant increase in cellular proliferation (Tinkle et al., 2008).
These findings, togetherwith our data (Figure 6BandFigureS5D),
demonstrate that hyperproliferation and Yap1 activation in the
absence of a-catenin are not simply due to loss of cell adhesion
and epithelial integrity. Additionally, in human cancers, loss of
a-catenin is usually a stronger prognostic factor than loss of E-
cadherin (Benjamin and Nelson, 2008). Thus, though it seems
that AJ components function coordinately in mediating keratino-
cyte adhesion, they differ in their ability to influence proliferative
responses. Particularly, it was shown that aberrant activation of
the Ras-MAPK pathway was partially responsible for the hyper-
proliferative phenotypes observed in a-catenin mutant skin
(Vasioukhin et al., 2001). It is still unclear to what extent Yap1,
Ras-MAPK, or other signaling pathways contribute to growth
suppression mediated by a-catenin in the skin. Whether Yap1
mediates all or only part of a-catenin tumor-suppressive activity
awaits the results of epistatic experiments in vivo.
14-3-3 and Yap1 Phosphorylation in the Skin
Our data would suggest that 14-3-3 proteins are also critical
growth suppressors in the epidermis. The 14-3-3 proteins are
a large group of highly conserved and homologous dimeric
proteins. A particular isoform, 14-3-3s, is unique among the
family in that it is selectively expressed in stratified epithelia.
Interestingly, 14-3-3s is barely detectable in basal cells but is
abundantly expressed in the suprabasal layer of human
epidermis (Dellambra et al., 2000). Downregulation of 14-3-3s
in primary keratinocytes results in the expansion and immortali-
zation of cells expressing p63 (Dellambra et al., 2000; Pellegrini
et al., 2001). Additionally, the epidermis of mice carrying a domi-792 Cell 144, 782–795, March 4, 2011 ª2011 Elsevier Inc.nant-negative mutation in 14-3-3s displays hyperplasia, expan-
sion of K14 and K5-expressing progenitor cells, and enhanced
proliferative capacity in vitro (Herron et al., 2005; Li et al.,
2005). These phenotypes are reminiscent of Yap1 overexpres-
sion and a-catenin deletion in the epidermis and further indicate
that 14-3-3s is part of a critical molecular circuitry controlling
epidermal progenitor expansion.
As predicted from work in Drosophila, Mst1/2 and Lats1/2 are
critical for Yap1 S127 phosphorylation in a wide array of cell lines
(Dong et al., 2007; Oh and Irvine, 2008; Zhao et al., 2007). Our
data here demonstrate that Mst1/2, and potentially Lats1/2,
are dispensable for Yap1 phosphorylation and activity in the
epidermis. Our results parallel those of Zhao et al. and identify
an unexpected diversity in the mammalian kinase components
that are necessary to phosphorylate Yap1 in relation to what is
predicted from work in Drosophila. For instance, in mouse liver,
Mst1/2 signal through an unknown intermediary kinase that is
distinct from Lats1/2 to control Yap1 phosphorylation. On the
other hand, mouse embryonic fibroblasts do not require Mst1/
2 but do depend on Lats1/2 to phosphorylate Yap1 (Zhao
et al., 2007). We have tested whether pharmacological manipu-
lation of MAP kinase and insulin signaling, pathways that were
previously shown to be involved in a-catenin signaling (Vasiou-
khin et al., 2001), had effects on Yap1 phosphorylation. Inhibition
of IGFR, JNK, and Src kinases resulted in no relative change in
Yap1-S127 phosphorylation (data not shown). Thus, the identity
of the kinases that are responsible for Yap1 inactivation in the
epidermis remains unknown.
Several examples exist in the literature that demonstrate that
competition between 14-3-3 proteins and PP2A complexes for
a substrate is critical for regulation (Chiang et al., 2003; Martin
et al., 2008). Our data suggest that binding of the Yap1/14-3-3
complex to a-catenin would stabilize this complex and/or inhibit
access of PP2Ac (Figure 7). When binding to a-catenin is lost,
PP2Ac could then more efficiently compete for binding to S127
in Yap1 and could dephosphorylate it, allowing Yap1 to translo-
cate into the nucleus, bind to TEADs, and activate a proprolifera-
tive gene expression program (Figure 7). Recently, a-catenin has
been found to interact with NF2, another upstream component of
the Hippo pathway (Gladden et al., 2010). Interestingly, it was re-
ported that NF2 could link a-catenin to Par3, thus providing
a bridge between AJs and polarity complexes. Together with
the recent identification of the apical polarity protein Crumbs as
a functional regulator of the Hippo pathway (Chen et al., 2010;
Grzeschik et al., 2010; Ling et al., 2010; Robinson et al., 2010;
Varelas et al., 2010), these findings raise the intriguing possibility
that a signaling complex of a-catenin, NF2, and other cell polarity
proteins that are associated with the cell membrane could make
up an important signaling hub that may allow cells to sense cues
such as density and positioning. These complexes then could
relay those signals to transcriptional effectors such as Yap1
(see below). The LIM protein Ajuba might provide an additional
avenue for crosstalk between AJs and Hippo signaling. Ajuba
can interactwitha-catenin andhas been recently shown to inhibit
Yap1 phosphorylation via interaction with Lats (Das Thakur et al.,
2010). Further studies are needed to determine whether and to
what extent a-catenin, NF2, and polarity complexes in epidermal
cells control proliferation through Yap1.
Crowd Control and the Hippo Pathway
An important longstanding question in the Hippo signaling field is
the identity of extracellular signals that modulate the pathway’s
activity. It has been speculated that this pathway could be
involved in interpreting morphogen gradients to regulate tissue
size, and therefore the existence of a secreted or membrane
ligand has been postulated (Harvey and Tapon, 2007). Our
data here suggest that, in the epidermis, this regulation is, at
least partly, mediated by a-catenin and AJs. Based on the
massive overgrowth phenotypes obtained by deletion of a-cate-
nin in the skin and the developing brain, Vasioukhin et al. postu-
lated that AJs could act as molecular biosensors of cell density
and positioning (Lien et al., 2006a, 2006b). Our data here support
and extend this notion and indicate that Yap1, through its inter-
action with a-catenin, is a critical mediator of this ‘‘crowd
control’’ molecular circuitry in the epidermis (Figure 7). In this
model, increased cellular density or differentiation (which is
sensed by an increased number of AJs), higher calcium concen-
tration (Menon and Elias, 1991), and selective expression of
14-3-3 in the suprabasal layers limit SC expansion by inactivat-
ing Yap1. Low basal cell density, as in a growing embryo or after
wounding, would translate into nuclear Yap1 and proliferation.
When this molecular network is defective, e.g., by deletion of
a-catenin, inactivation of 14-3-3, or activation of Yap1, hyper-
proliferation and tumors can arise. Further elucidation of the
transcriptional program controlled by Yap1 and identification
of modulators of its interaction with a-catenin, including the
kinase that mediates Yap1 inactivation in keratinocytes, will
likely provide insights into the mechanisms that underlie SC
maintenance, tissue expansion, and tumorigenesis.
EXPERIMENTAL PROCEDURES
Generation of Gene-Targeted Mice
For generation of cKO mice, a targeting strategy was designed to allow Cre-
mediated deletion of exon 1 and 2 of Yap1. Progeny carrying the targeted
Yap1 allele were bred to K14-Cre mice. To generate the mutated Yap1S79A
allele, a point mutation was introduced by site-directed PCR mutagenesis in
the mYap1-targeting construct substituting a serine at amino acid position
79 (TCC) for an alanine (GCG). Mice were generated in the same way as
described for the Yap1fl/fl mice. Mice carrying the Yap1S79A allele were bred
to K14-Cre Yap1fl/+ mice to generate K14 Cre Yap1S79A/fl mice.
Cell Isolation, In Vitro Culture, and Clonogenic Assays
Primary keratinocytes isolated from the epidermis of E18.5 control and trans-
genic mice were cultured on mitomycin-C-treated 3T3 feeder cells in FAD
medium. For clonogenic assays, colonies of primary mouse keratinocytes
were fixed and stained with 1% rhodamine B (Sigma) 9 days after initial plating.
Skin Engraftments and Barrier Function Assay
Full thickness skins of E18.5 K14-Cre Yap1fl/fl and littermate Ctr mice were
removed from torsos and spread on a sterile petri dish and briefly stored at
4C. During this time, each skin graft recipient site was prepared by removal
of a patch of full thickness skin on the back of an anesthetized Foxn1nu/
Foxn1nu mouse. For skin barrier assays, newborn mice were rinsed in PBS
and successively dehydrated in methanol for 1 min each. Mice were then rehy-
dratedwith PBS and stained in 0.1% toluidine blue in PBS, destainedwith PBS
for 20 min, and then photographed.
Mass Spectrometry and Proteomic Analysis
Approximately 4 mg of precleared high-density HaCaT cells were used
for Yap1 immunoprecipitation. Immunoprecipitates were loaded ontoSDS-PAGE and stained with colloidal Coomassie. Mass spectrometry analysis
was performed at the proteomics facility at Children’s Hospital Boston.
Dephosphorylation Assay
Catalytically active recombinant PP2A (PP2Ac) was purchased from Millipore.
Recombinant proteins were incubated in the presence of varying concentra-
tions of PP2Ac. For PP2Ac and 14-3-3 competition assays, Yap1, a-catenin,
and 14-3-3 were preincubated in 50 mM Tris (pH 7.4), 150 mM NaCl, 5 mM
MgCl2, and 0.02% Triton X-100 for 1 hr prior to PP2Ac addition.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and one table and can be found with this article online at doi:10.1016/j.
cell.2011.02.031.
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